In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...

Researchers in China reported successful transcatheter aortic valve replacements using a novel repositionable and retrievable self-expanding valve in 10 patients with severe symptomatic aortic ...

People didn't have to wait long after transcatheter aortic valve replacement (TAVR or TAVI) to safely undergo noncardiac surgery, though suboptimal device performance should give pause for another ...

SAN ANTONIO -- The early experience of patients needing cardiac surgery after transcatheter aortic valve replacement (TAVR) has surgeons raising the alarm about the excess risks of these challenging ...

The new system offers surgeons a larger coronary access window and increased space to facilitate access to a patient’s coronary arteries. This leads to lower mortality rates, lower stroke rates and ...

An Oct. 21 study in Circulation: Cardiovascular Quality and Outcomes found that most transcatheter aortic valve replacement programs are found in affluent metropolitan areas. Researchers identified ...

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA ...

The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is more ...